StoxCaplin Point Laboratories vs Rainbow Childrens Medicare: share price & financials comparison
NSE: CAPLIPOINT vs RAINBOW · Healthcare · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Caplin Point Laboratories vs Rainbow Childrens Medicare at a glance
Caplin Point Laboratories (CAPLIPOINT) has a market capitalisation of ₹18,154 Cr, against ₹12,914 Cr for Rainbow Childrens Medicare (RAINBOW). Over the past year Caplin Point Laboratories has returned +19.7%, compared with -8.6% for Rainbow Childrens Medicare. On valuation, Caplin Point Laboratories trades at a lower P/E of 26.3 versus 44.2. Caplin Point Laboratories earns a higher return on equity (17.7% vs 17.0%). Caplin Point Laboratories comes out ahead on size, valuation, profitability, growth, momentum and technicals. Across the scored metrics below, Caplin Point Laboratories leads on 13 and Rainbow Childrens Medicare on 2. On StoxGud's 10-point checklist, Caplin Point Laboratories scores 9/10 and Rainbow Childrens Medicare scores 5/10.
| Metric | Caplin Point Laboratories | Rainbow Childrens Medicare |
|---|---|---|
| Size | ||
| Market cap | ₹18,154 Cr | ₹12,914 Cr |
| Revenue (latest FY) | ₹2,187 Cr | ₹1,703 Cr |
| Net profit (latest FY) | ₹641 Cr | ₹278 Cr |
| Valuation | ||
| P/E | 26.3 | 44.2 |
| P/B | 4.65 | 7.53 |
| Dividend yield | 0.25% | 0.24% |
| Profitability | ||
| Return on equity | 17.7% | 17.0% |
| Net profit margin | 28.9% | 15.2% |
| Operating margin | 34.9% | 31.0% |
| Growth | ||
| Revenue growth (YoY) | +17.9% | +23.2% |
| Net profit growth (YoY) | +15.3% | +9.1% |
| Revenue CAGR (multi-year) | +15.6% | +15.0% |
| Financial health | ||
| Debt to equity | 0.00 | 0.00 |
| Momentum | ||
| 1-month return | +1.1% | +4.5% |
| 1-year return | +19.7% | -8.6% |
| 3-year CAGR | +23.7% | +7.7% |
| 5-year CAGR | +22.7% | — |
| 10-year CAGR | +21.3% | — |
| Distance from 52W high | -16.7% | -20.5% |
| Technicals | ||
| RSI (14) | 64 | 71 |
| Price vs 200-day avg | +9.1% | -3.8% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Caplin Point Laboratories | Rainbow Childrens Medicare |
|---|---|---|
| Price above 50-day average | ✗ | ✗ |
| Price above 200-day average | ✓ | ✗ |
| 50-day average above 200-day (uptrend) | ✓ | ✗ |
| RSI in healthy 40–70 zone | ✓ | ✗ |
| Positive 1-year return | ✓ | ✗ |
| Return on equity above 15% | ✓ | ✓ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✓ | ✓ |
| P/E below industry median | ✓ | ✓ |
| Score | 9/10 | 5/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Caplin Point Laboratories or Rainbow Childrens Medicare?
Caplin Point Laboratories has a market cap of ₹18,154 Cr and Rainbow Childrens Medicare has a market cap of ₹12,914 Cr as of 13 Nov 2026.
Which has a lower P/E, Caplin Point Laboratories or Rainbow Childrens Medicare?
Caplin Point Laboratories has the lower P/E: Caplin Point Laboratories trades at 26.3 and Rainbow Childrens Medicare at 44.2.
Which gave better returns in the last year, Caplin Point Laboratories or Rainbow Childrens Medicare?
Caplin Point Laboratories did better: Caplin Point Laboratories returned +19.7% and Rainbow Childrens Medicare returned -8.6% over one year.
What is the difference between Caplin Point Laboratories and Rainbow Childrens Medicare?
Both are NSE-listed companies in Healthcare. Caplin Point Laboratories is about 1.4 times the size of Rainbow Childrens Medicare by market cap. In the latest financial year Caplin Point Laboratories reported revenue of ₹2,187 Cr and Rainbow Childrens Medicare ₹1,703 Cr. Operating margin is 34.9% for Caplin Point Laboratories and 31.0% for Rainbow Childrens Medicare. Debt to equity is 0.00 for Caplin Point Laboratories and 0.00 for Rainbow Childrens Medicare.
Which is better, Caplin Point Laboratories or Rainbow Childrens Medicare?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Caplin Point Laboratories leads on 13 and Rainbow Childrens Medicare on 2. Caplin Point Laboratories is ahead on size, valuation, profitability, growth, momentum and technicals. On StoxGud's rules-based checklist Caplin Point Laboratories scores 9/10 and Rainbow Childrens Medicare scores 5/10. This is information, not advice: consult a SEBI-registered adviser before investing.